Abmaxis

Abmaxis is a biopharmaceutical company dedicated to the discovery and optimization of monoclonal antibody (MAb) products for human therapeutics and diagnostics. It was acquired by Merck in 2006.

Shirley Clayton, CEO
Springboard Alumna, 2004